Reference Datasets for 2-Treatment, 2-Sequence, 2-Period Bioequivalence Studies

Apply

Reference Datasets for 2-Treatment, 2-Sequence, 2-Period Bioequivalence Studies

Journal Title: The AAPS Journal - Year 2014, Vol 16, Issue 6

Abstract

The online version of this article (doi:10.1208/s12248-014-9661-0) contains supplementary material, which is available to authorized users.

Authors and Affiliations

Helmut Schütz, Detlew Labes, Anders Fuglsang

Keywords

bioequivalence crossover software validation

It’s time

Statistical inference involves taking the results of models and knowledge about probability to make decisions about the relationship in question. This commentary explains the usefulness of statistical inference to the dr...

Physiologically Based Pharmacokinetic Models in the Prediction of Oral Drug Exposure Over the Entire Pediatric Age Range—Sotalol as a Model Drug

In recent years, the increased interest in pediatric research has enforced the role of physiologically based pharmacokinetic (PBPK) models in pediatric drug development. However, an existing lack of published examples co...

Immunogenicity of Subcutaneously Administered Therapeutic Proteins—a Mechanistic Perspective

The administration of therapeutic proteins via the subcutaneous route (sc) is desired for compliance and convenience, but could be challenging due to perceived immunogenic potential or unwanted immune responses. There ar...

Analysis of Imprecision in Incurred Sample Reanalysis for Small Molecules

Over the years, incurred sample (IS) reanalysis (ISR) has become a tool to confirm the reliability of bioanalytical measurements. The recommendation for ISR acceptance criterion for small molecules is at least 67% of ISR...